Updated 08 January 2013
As of 1 January 2013, the fees payable for medicinal products and companies, etc. are established in Executive Order no. 1407 of 20 December 2012 on Fees Payable for Medicinal Products, etc (pdf). Please find the applicable fees in Schedule 1.
We send out invoices payable within one month.
Increased fee applicable to the manufacture of medicines outside EU/EEA
When a medicinal product is manufactured at a company in a third country, i.e. outside the EU/EEA, an increased application fee and an increased annual fee are charged.
In 2013, the increased fee/annual fee is DKK 6,860. However, the fee is payable for maximum one strength per pharmaceutical form.
The increased annual fee has item number 30368, and the increased fee has item number 30369.
The increased application fee is charged currently, whereas the increased annual fee is charged at the end of each year.